In last trading session, Applied Therapeutics Inc (NASDAQ:APLT) saw 1.27 million shares changing hands with its beta currently measuring 1.93. Company’s recent per share price level of $0.47 trading at $0.03 or 7.36% at ring of the bell on the day assigns it a market valuation of $66.53M. That closing price of APLT’s stock is at a discount of -2159.57% from its 52-week high price of $10.62 and is indicating a premium of 38.3% from its 52-week low price of $0.29. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.22 million shares which gives us an average trading volume of 2.37 million if we extend that period to 3-months.
For Applied Therapeutics Inc (APLT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.25. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Applied Therapeutics Inc (NASDAQ:APLT) trade information
Applied Therapeutics Inc’s shares saw a change of -92.09% in year-to-date performance and have moved 13.48% in past 5-day. Applied Therapeutics Inc (NASDAQ:APLT) showed a performance of 26.93% in past 30-days. Number of shares sold short was 21.33 million shares which calculate 8.79 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 4.5 to the stock, which implies a rise of 89.56% to its current value. Analysts have been projecting 4 as a low price target for the stock while placing it at a high target of 5. It follows that stock’s current price would drop -751.06% in reaching the projected high whereas dropping to the targeted low would mean a loss of -751.06% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 26.57% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 21.05% while estimates for its earnings growth in next 5 years are of 24.56%.
Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders
Insiders are in possession of 5.49% of company’s total shares while institution are holding 83.05 percent of that, with stock having share float percentage of 87.87%. Investors also watch the number of corporate investors in a company very closely, which is 83.05% institutions for Applied Therapeutics Inc that are currently holding shares of the company. FRANKLIN RESOURCES INC is the top institutional holder at APLT for having 10.21 million shares of worth $47.69 million. And as of 2024-06-30, it was holding 70.7533 of the company’s outstanding shares.
The second largest institutional holder is VR ADVISER, LLC, which was holding about 9.54 million shares on 2024-06-30. The number of shares represents firm’s hold over 66.1112 of outstanding shares, having a total worth of $44.57 million.
On the other hand, T. Rowe Price Small-Cap Value Fund, Inc. and Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 6.47 shares of worth $3.04 million or 4.57% of the total outstanding shares. The later fund manager was in possession of 4.49 shares on Mar 31, 2025 , making its stake of worth around $2.11 million in the company or a holder of 3.17% of company’s stock.
